Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Scanlon

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biotechnology and Bioengineering|July 11, 2019
Erratum for "A high-throughput screen for antibiotic drug discovery" (Volume 111, issue 2, pp. 232-243)Thomas C Scanlon, Sarah M Dostal, Karl E Griswold
BMC Biotechnology|November 26, 2009
Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid librariesThomas C Scanlon, Elizabeth C Gray, Karl E Griswold
Biotechnology and Bioengineering|August 20, 2013
A high-throughput screen for antibiotic drug discoveryThomas C Scanlon, Sarah M Dostal, Karl E Griswold
Bioengineered Bugs|February 18, 2011
The monoclonal mythThomas C Scanlon, Heather L Jewell, Elizabeth C Gray, et al.
Plos One|March 17, 2011
Crystal structure of a charge engineered human lysozyme having enhanced bactericidal activityAvinash Gill, Thomas C Scanlon, Daniel C Osipovitch, et al.
Electrophoresis|May 24, 2024
An immuno-northern technique to measure the size of dsRNA byproducts in in vitro transcribed RNANathaniel E Clark, Matthew R Schraut, Roger A Winters, et al.
ACS Chemical Biology|January 22, 2015
Genetically enhanced lysozyme evades a pathogen derived inhibitory proteinSarah M Dostal, Yongliang Fang, Jonathan C Guerrette, et al.
Plos One|February 23, 2011
Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivityJohn W Lamppa, Margaret E Ackerman, Jennifer I Lai, et al.
Experimental Cell Research|November 18, 2008
Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography methodThomas C Scanlon, Bruce Gottlieb, Thomas M Durcan, et al.
Bioengineered|March 19, 2014
Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infectionsKarl E Griswold, Jenna L Bement, Charlotte C Teneback, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biotechnology and Bioengineering|July 11, 2019
Erratum for "A high-throughput screen for antibiotic drug discovery" (Volume 111, issue 2, pp. 232-243)Thomas C Scanlon, Sarah M Dostal, Karl E Griswold
BMC Biotechnology|November 26, 2009
Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid librariesThomas C Scanlon, Elizabeth C Gray, Karl E Griswold
Biotechnology and Bioengineering|August 20, 2013
A high-throughput screen for antibiotic drug discoveryThomas C Scanlon, Sarah M Dostal, Karl E Griswold
Bioengineered Bugs|February 18, 2011
The monoclonal mythThomas C Scanlon, Heather L Jewell, Elizabeth C Gray, et al.
Plos One|March 17, 2011
Crystal structure of a charge engineered human lysozyme having enhanced bactericidal activityAvinash Gill, Thomas C Scanlon, Daniel C Osipovitch, et al.
Electrophoresis|May 24, 2024
An immuno-northern technique to measure the size of dsRNA byproducts in in vitro transcribed RNANathaniel E Clark, Matthew R Schraut, Roger A Winters, et al.
ACS Chemical Biology|January 22, 2015
Genetically enhanced lysozyme evades a pathogen derived inhibitory proteinSarah M Dostal, Yongliang Fang, Jonathan C Guerrette, et al.
Plos One|February 23, 2011
Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivityJohn W Lamppa, Margaret E Ackerman, Jennifer I Lai, et al.
Experimental Cell Research|November 18, 2008
Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography methodThomas C Scanlon, Bruce Gottlieb, Thomas M Durcan, et al.
Bioengineered|March 19, 2014
Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infectionsKarl E Griswold, Jenna L Bement, Charlotte C Teneback, et al.
Pageof 2